Protective effects of edaravone on experimental spinal cord injury in rats

Pediatric Neurosurgery

Volumn 47, Issue 4, 2012, Pages 254-260

  Özgiray, Erkin ^b   Serarslan, Yurdal ^a   Öztürk, Oktay Hasan ^a   Altaş, Murat ^a   Aras, Mustafa ^a   Söǧüt, Sadk ^a   Yurtseven, Taşkn ^b   Oran, Ismail ^b   Zileli, Mehmet ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Edaravone; Rat; Spinal cord injury; Total antioxidant capacity

Indexed keywords

BICUN; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; METHYLPREDNISOLONE ACETATE; NITRIC OXIDE; NORPHENAZONE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; MALE; NEUROLOGIC EXAMINATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SPINAL CORD INJURY;

ANIMALS; ANTIPYRINE; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; MALE; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SPINAL CORD; SPINAL CORD INJURIES;

EID: 84861096511     PISSN: 10162291     EISSN: 14230305     Source Type: Journal    
DOI: 10.1159/000335400     Document Type: Article

References (42)

1. Heinzelmann M, Eid K, Boos N: Cervical spine injuries; in Boos N, Aebi M (eds): Spinal Disorders. Berlin, Springer, 2008, pp 825-882.
2. Hurlbert RJ: Strategies of medical intervention in the management of acute spinal cord injury. Spine (Phila Pa 1976) 2006; 31(suppl): S16-S21.
3. Cayli SR, Ates O, Karadag N, Altinoz E, Yucel N, Yologlu S, Kocak A, Cakir CO: Neuroprotective effect of etomidate on functional recovery in experimental spinal cord injury. Int J Dev Neurosci 2006; 24: 233-239.
4. GörgülüA, Kiris T, Unal F, Turkoglu U, Küçük M, Cobanoglu S: Superoxide dismutase activity and the effects of NBQX and CPP on lipid peroxidation in experimental spinal cord injury. Res Exp Med (Berl) 2000; 199: 285-293.
5. Kahraman S, Düz B, Kayali H, Korkmaz A, Oter S, Aydin A, Sayal A: Effects of methylprednisolone and hyperbaric oxygen on oxidative status after experimental spinal cord injury: A comparative study in rats. Neurochem Res 2007; 32: 1547-1551.
6. Serarslan Y, Yönden Z, Ozgiray E, Oktar S, Güven EO, Sögüt S, Yilmaz N, Yurtseven T: Protective effects of tadalafil on experimental spinal cord injury in rats. J Clin Neurosci 2010; 17: 349-352.
7. Braughler JM, Hall ED: Central nervous system trauma and stroke. 1. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med 1989; 6: 2289-2301.
8. Kalayci M, Coskun O, Cagavi F, Kanter M, Armutcu F, Gul S, Acikgoz B: Neuroprotective effects of ebselen on experimental spinal cord injury in rats. Neurochem Res 2005; 30: 403-410.
9. Kurt G, Ergün E, Cemil B, Börcek AO, Börcek P, Gülbahar O, Ceviker N: Neuroprotective effects of infliximab in experimental spinal cord injury. Surg Neurol 2009; 71: 332-336.
10. Sahin S, Sögüt S,özyurt H, Uz E, Ilhan A, Akyol O: Tissue xanthine oxidase activity and nitric oxide levels after spinal cord ischemia/reperfusion injury in rabbits: Comparison of caffeic acid phenethyl ester (CAPE) and methylprednisolone. Neurosci Res Commun 2002; 31: 111-121.
11. Kikuchi K, Kawahara K, Tancharoen S, Matsuda F, Morimoto Y, Ito T, Biswas KK, Takenouchi K, Miura N, Oyama Y, Nawa Y, Arimura N, Iwata M, Tajima Y, Kuramoto T, Nakayama K, Shigemori M, Yoshida Y, Hashiguchi T, Maruyama I: The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells. J Pharmacol Exp Ther 2009; 329: 865-874.
12. Kubo K, Nakao S, Jomura S, Sakamoto S, Miyamoto E, Xu Y, Tomimoto H, Inada T, Shingu K: Edaravone, a free radical scavenger, mitigates both gray and white matter damages after global cerebral ischemia in rats. Brain Res 2009; 1279: 139-146.
13. Munakata A, Ohkuma H, Nakano T, Shimamura N, Asano K, Naraoka M: Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2009; 64: 423-428.
14. Tanaka M: Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent. Nippon Yakurigaku Zasshi 2002; 119: 301-308.
15. Ueno Y, Zhang N, Miyamoto N, Tanaka R, Hattori N, Urabe T: Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model. Neuroscience 2009; 162: 317-327.
16. Watanabe T, Tahara M, Todo S: The novel antioxidant edaravone: From bench to bedside. Cardiovasc Ther 2008; 26: 101-114.
17. Watanabe T, Yuki S, Egawa M, Nishi H: Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 1994; 268: 1597-1604.
18. Aoyama T, Hida K, Kuroda S, Seki T, Yano S, Shichinohe H, Iwasaki Y: Edaravone (MCI-186) scavenges reactive oxygen species and ameliorates tissue damage in the murine spinal cord injury model. Neurol Med Chir (Tokyo) 2008; 48: 539-545.
19. Hamaishi M, Orihashi K, Isaka M, Kumagai H, Takahashi S, Okada K, Ohtaki M, Sueda T: Low-dose edaravone injection into the clamped aorta prevents ischemic spinal cord injury. Ann Vasc Surg 2009; 23: 128-135.
20. Zhou F, Chen G, Zhang J: Edaravone reduces brain oedema and attenuates cell death after intracerebral haemorrhage in mice. Brain Inj 2009; 23: 353-357.
21. Constantini S, Young W: The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J Neurosurg 1994; 80: 97-111.
22. Tarlov IM: Acute spinal cord compression paralysis. J Neurosurg 1972; 36: 10-20.
23. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-421.
24. Cortas NK, Wakid NW: Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36: 1440-1443.
25. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
26. Erel O: A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119.
27. Sun Y, Oberley LW, Li Y: A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
29. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J, et al: A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322: 1405-1411.
30. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, Fehlings MG, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL Jr, Piepmeier J, Sonntag VK, Wagner F, Wilberger JE, Winn HR, Young W: Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up: Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998; 89: 699-706.
31. Ohta S, Iwashita Y, Takada H, Kuno S, Nakamura T: Neuroprotection and enhanced recovery with edaravone after acute spinal cord injury in rats. Spine (Phila Pa 1976) 2005; 30: 1154-1158.
32. Takahashi G, Sakurai M, Abe K, Itoyama Y, Tabayashi K: MCI-186 prevents spinal cord damage and affects enzyme levels of nitric oxide synthase and Cu/Zn superoxide dismutase after transient ischemia in rabbits. J Thorac Cardiovasc Surg 2003; 126: 1461-1466.
33. Takahashi G, Sakurai M, Abe K, Itoyama Y, Tabayashi K: MCI-186 reduces oxidative cellular damage and increases DNA repair function in the rabbit spinal cord after transient ischemia. Ann Thorac Surg 2004; 78: 602-607.
34. Erol FS, Kaplan M, Tiftikci M, Yakar H, Ozercan I, Ilhan N, Topsakal C: Comparison of the effects of octreotide and melatonin in preventing nerve injury in rats with experimental spinal cord injury. J Clin Neurosci 2008; 15: 784-790.
35. Kanter M, Coskun O, Kalayci M, Buyukbas S, Cagavi F: Neuroprotective effects of Nigella sativa on experimental spinal cord injury in rats. Hum Exp Toxicol 2006; 25: 127-133.
36. Altug ME, Serarslan Y, Bal R, Kontas T, Ekici F, Melek IM, Aslan H, Duman T: Caffeic acid phenethyl ester protects rabbit brains against permanent focal ischemia by antioxidant action: A biochemical and planimetric study. Brain Res 2008; 1201: 135-142.
37. Serarslan Y, Bal R, Altug ME, Kontas T, Keles ON, Unal D, Unal B: Effects of trimetazidine on crush injury of the sciatic nerve in rats: A biochemical and stereological study. Brain Res 2009; 1247: 11-20.
38. Taskiran D, Tanyalcin T, Sozmen EY, Peker GO, Gulmen V, Cagli S, Kanit L, Tekeli G, Barcin E, Zileli M, Kutay FZ: The effects of melatonin on the antioxidant systems in experimental spinal injury. Int J Neurosci 2000; 104: 63-73.
39. Ozdogan M, Devay AO, Gurer A, Ersoy E, Devay SD, Kulacoglu H, Gundogdu H: Plasma total anti-oxidant capacity correlates inversely with the extent of acute appendicitis: A case control study. World J Emerg Surg 2006; 24: 6.
40. Gariballa SE, Hutchin TP, Sinclair AJ: Antioxidant capacity after acute ischaemic stroke. QJM 2002; 95: 685-690.
41. Rice-Evans C, Miller NJ: Total antioxidant status in plasma and body fluids. Methods Enzymol 1994; 234: 279-293.
42. Alonso de Vega JM, Diaz J, Serrano E, Carbonell LF: Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002; 30: 1782-1786.